Alkami Technology (ALKT) Financials

$25.69 +0.42 (+1.66%)

Closing price 04:00 PM Eastern

Extended Trading

$25.68 -0.01 (-0.04%)

As of 05:26 PM Eastern

Annual Income Statements for Alkami Technology

This table shows Alkami Technology's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2019	2020	2021	2022	2023	2024
Period end date	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	-43	-57	-47	-59	-63	-41
Consolidated Net Income / (Loss)	-42	-51	-47	-59	-63	-41
Net Income / (Loss) Continuing Operations	-42	-51	-47	-59	-63	-41
Total Pre-Tax Income	-42	-51	-47	-59	-63	-41
Total Operating Income	-43	-35	-43	-58	-64	-45
Total Gross Profit	30	59	84	108	144	197
Total Revenue	74	112	152	204	265	334
Operating Revenue	74	112	152	204	265	334
Total Cost of Revenue	43	53	68	96	121	137
Operating Cost of Revenue	43	53	68	96	121	137
Total Operating Expenses	73	94	127	166	208	241
Selling, General & Admin Expense	25	36	50	71	73	84
Marketing Expense	15	17	24	37	49	60
Research & Development Expense	33	40	49	69	85	96
Restructuring Charge	-	0.84	2.98	-13	0.26	0.20
Total Other Income / (Expense), net	0.67	-16	-3.73	-1.37	0.84	4.10
Interest Expense	0.11	0.49	1.19	3.87	7.79	0.46
Interest & Investment Income	0.27	0.06	0.49	2.70	8.10	4.56
Other Income / (Expense), net	0.51	-16	-3.04	-0.20	0.53	0.00
Income Tax Expense	0.00	0.00	0.17	-0.46	0.04	0.31
Basic Earnings per Share	($9.91)	($11.78)	($0.73)	($0.64)	($0.67)	($0.41)
Weighted Average Basic Shares Outstanding	4.35M	4.81M	64.51M	90.96M	94.08M	98.89M
Diluted Earnings per Share	($9.91)	($11.78)	($0.73)	($0.64)	($0.67)	($0.41)
Weighted Average Diluted Shares Outstanding	4.35M	4.81M	64.51M	90.96M	94.08M	98.89M
Weighted Average Basic & Diluted Shares Outstanding	-	-	90.22M	92.30M	96.76M	102.23M

This table shows Alkami Technology's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025
Net Income / (Loss) Attributable to Common Shareholders	-20	-4.91	-17	-18	-15	-13	-11	-12	-9.44	-7.64	-7.82
Consolidated Net Income / (Loss)	-20	-4.91	-17	-18	-15	-13	-11	-12	-9.44	-7.64	-7.82
Net Income / (Loss) Continuing Operations	-20	-4.91	-17	-18	-15	-13	-11	-12	-9.44	-7.64	-7.82
Total Pre-Tax Income	-20	-5.45	-17	-18	-15	-13	-11	-12	-9.46	-7.69	-15
Total Operating Income	-20	-5.48	-17	-18	-16	-13	-12	-13	-10	-8.63	-15
Total Gross Profit	28	29	32	35	37	40	44	49	51	53	58
Total Revenue	53	56	60	66	68	71	76	82	86	90	98
Operating Revenue	53	56	60	66	68	71	76	82	86	90	98
Total Cost of Revenue	26	27	28	30	31	31	32	33	35	36	40
Operating Cost of Revenue	26	27	28	30	31	31	32	33	35	36	40
Total Operating Expenses	47	34	49	53	52	53	56	62	61	62	73
Selling, General & Admin Expense	18	17	17	18	18	19	19	21	22	22	24
Marketing Expense	9.72	8.99	11	14	12	12	14	17	14	15	18
Research & Development Expense	18	20	21	21	22	21	23	24	24	25	27
Impairment Charge	-	-	-	-	-	-	-	-	-	-	1.66
Restructuring Charge	0.74	-13	0.19	0.03	0.00	0.04	0.06	0.14	0.00	-	2.38
Total Other Income / (Expense), net	-0.39	0.03	0.18	0.20	0.35	0.11	1.12	1.08	0.97	0.94	0.30
Interest Expense	1.19	1.53	1.76	1.83	1.93	2.28	0.07	0.07	0.18	0.13	0.80
Interest & Investment Income	0.85	1.31	1.73	2.02	2.08	2.27	1.08	1.26	1.15	1.07	1.10
Other Income / (Expense), net	-0.06	0.25	0.21	0.01	0.20	0.11	0.11	-0.11	0.00	-	0.00
Income Tax Expense	-0.16	-0.54	0.20	0.09	0.04	-0.28	0.19	0.19	-0.02	-0.05	-7.29
Basic Earnings per Share	($0.22)	($0.05)	($0.18)	($0.19)	($0.16)	($0.14)	($0.12)	($0.13)	($0.09)	($0.07)	($0.08)
Weighted Average Basic Shares Outstanding	91.18M	90.96M	92.40M	93.33M	94.68M	94.08M	96.95M	98.10M	99.44M	98.89M	102.43M
Diluted Earnings per Share	($0.22)	($0.05)	($0.18)	($0.19)	($0.16)	($0.14)	($0.12)	($0.13)	($0.09)	($0.07)	($0.08)
Weighted Average Diluted Shares Outstanding	91.18M	90.96M	92.40M	93.33M	94.68M	94.08M	96.95M	98.10M	99.44M	98.89M	102.43M
Weighted Average Basic & Diluted Shares Outstanding	91.48M	92.30M	92.86M	94.23M	95.36M	96.76M	97.52M	98.99M	100.50M	102.23M	103.02M

This table details how cash moves in and out of Alkami Technology's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2019	2020	2021	2022	2023	2024
Period end date	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	-13	160	141	-201	-71	53
Net Cash From Operating Activities	-39	-38	-29	-38	-18	19
Net Cash From Continuing Operating Activities	-39	-38	-29	-38	-18	19
Net Income / (Loss) Continuing Operations	-42	-51	-47	-59	-63	-41
Consolidated Net Income / (Loss)	-42	-51	-47	-59	-63	-41
Depreciation Expense	2.23	2.78	3.44	8.08	11	11
Amortization Expense	0.04	0.06	0.05	0.13	0.14	0.21
Non-Cash Adjustments To Reconcile Net Income	1.25	18	18	44	48	58
Changes in Operating Assets and Liabilities, net	-0.74	-7.40	-3.20	-32	-13	-9.65
Net Cash From Investing Activities	-3.69	-27	-22	-224	34	23
Net Cash From Continuing Investing Activities	-3.69	-27	-22	-224	34	23
Purchase of Property, Plant & Equipment	-3.69	-2.15	-3.70	-4.45	-6.29	-7.86
Acquisitions	0.00	-25	-18	-132	0.00	0.00
Purchase of Investments	-	0.00	0.00	-187	-141	-40
Sale and/or Maturity of Investments	-	0.00	0.00	100	181	71
Net Cash From Financing Activities	30	225	192	61	-88	12
Net Cash From Continuing Financing Activities	30	225	192	61	-88	12
Repayment of Debt	-0.11	-13	-0.31	-25	-85	-0.36
Issuance of Debt	0.00	38	0.00	85	0.00	0.00
Issuance of Common Equity	0.00	0.00	196	2.91	4.12	4.74
Other Financing Activities, net	0.31	1.99	9.76	-1.27	-6.60	7.42
Cash Interest Paid	0.06	0.35	1.10	3.61	7.06	0.28
Cash Income Taxes Paid	0.08	0.07	0.03	0.25	0.33	0.38

This table details how cash moves in and out of Alkami Technology's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025
Net Change in Cash & Equivalents	7.54	8.21	5.58	-25	-14	-38	3.25	17	20	13	-33
Net Cash From Operating Activities	-4.75	-14	-9.62	-5.71	3.13	-5.31	0.95	0.55	11	6.11	-5.66
Net Cash From Continuing Operating Activities	-4.75	-14	-9.62	-5.71	3.13	-5.31	0.95	0.55	11	6.11	-5.66
Net Income / (Loss) Continuing Operations	-20	-4.91	-17	-18	-15	-13	-11	-12	-9.44	-7.64	-7.82
Consolidated Net Income / (Loss)	-20	-4.91	-17	-18	-15	-13	-11	-12	-9.44	-7.64	-7.82
Depreciation Expense	2.55	2.56	2.59	2.56	2.70	2.79	2.56	2.61	2.68	2.65	3.43
Amortization Expense	0.01	0.02	0.05	0.04	0.03	0.03	0.03	0.03	0.10	0.05	0.19
Non-Cash Adjustments To Reconcile Net Income	12	11	11	12	12	12	13	15	15	15	17
Changes in Operating Assets and Liabilities, net	1.11	-23	-6.12	-2.76	3.87	-7.86	-3.36	-4.41	2.54	-4.42	-19
Net Cash From Investing Activities	12	24	16	-16	-16	50	6.81	15	3.77	-3.01	-389
Net Cash From Continuing Investing Activities	12	24	16	-16	-16	50	6.81	15	3.77	-3.01	-389
Purchase of Property, Plant & Equipment	-0.72	-0.88	-1.37	-1.71	-1.54	-1.68	-1.67	-2.08	-2.30	-1.81	-1.93
Acquisitions	0.69	-0.50	-	-	-	-	-	-	-	-	-375
Purchase of Investments	-21	-23	-21	-42	-47	-31	-7.15	-8.44	-15	-9.70	-22
Sale and/or Maturity of Investments	33	48	38	28	32	83	16	26	21	8.50	9.90
Net Cash From Financing Activities	0.31	-1.71	-0.57	-3.45	-0.78	-83	-4.51	1.24	4.77	10	362
Net Cash From Continuing Financing Activities	0.31	-1.71	-0.57	-3.45	-0.78	-83	-4.51	1.24	4.77	10	362
Repayment of Debt	0.08	-	-	-	-1.06	-83	-	-	-0.36	-	-0.78
Issuance of Debt	-	-	-	-	-	-	-	-	-	-	396
Other Financing Activities, net	0.23	-2.78	-0.57	-4.46	0.28	-1.86	-4.51	-1.36	5.13	8.16	-32

This table presents Alkami Technology's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2020	2021	2022	2023	2024
Period end date	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Total Assets	249	437	489	400	437
Total Current Assets	193	345	242	149	181
Cash & Equivalents	167	309	109	41	94
Short-Term Investments	-	0.00	88	51	21
Accounts Receivable	14	21	26	35	39
Prepaid Expenses	7.60	9.49	12	11	14
Other Current Assets	4.75	6.27	7.86	10	13
Plant, Property, & Equipment, net	10	12	14	17	22
Total Noncurrent Assets	45	80	233	234	234
Goodwill	16	48	148	148	148
Intangible Assets	8.27	11	43	36	29
Other Noncurrent Operating Assets	21	20	43	50	57
Total Liabilities & Shareholders' Equity	249	437	489	400	437
Total Liabilities	69	92	155	75	80
Total Current Liabilities	20	33	42	39	46
Accounts Payable	0.36	3.65	4.29	7.48	6.13
Accrued Expenses	13	19	22	20	25
Current Deferred Revenue	6.71	8.90	8.84	11	14
Other Current Liabilities	-	0.00	3.66	1.21	1.34
Total Noncurrent Liabilities	49	59	113	35	35
Noncurrent Deferred Revenue	20	19	14	15	16
Noncurrent Deferred & Payable Income Tax Liabilities	0.00	0.09	1.71	1.71	1.82
Other Noncurrent Operating Liabilities	4.09	17	16	18	17
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	-264	345	334	325	357
Total Preferred & Common Equity	-264	345	334	325	357
Preferred Stock	0.00	0.00	0.00	0.00	0.00
Total Common Equity	-264	345	334	325	357
Common Stock	0.01	658	706	760	833
Retained Earnings	-264	-314	-372	-435	-476

This table presents Alkami Technology's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025
Period end date	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025
Total Assets	485	482	473	482	398	404	422	837
Total Current Assets	255	237	226	233	146	152	169	174
Cash & Equivalents	97	114	90	76	44	61	81	62
Short-Term Investments	112	71	86	102	43	26	20	34
Accounts Receivable	26	28	28	31	36	39	42	47
Prepaid Expenses	13	14	13	14	12	14	14	19
Other Current Assets	7.05	8.44	8.92	9.50	11	11	12	14
Plant, Property, & Equipment, net	13	14	15	16	18	20	21	23
Total Noncurrent Assets	217	231	231	233	234	232	232	640
Goodwill	146	148	148	148	148	148	148	400
Intangible Assets	44	41	39	38	34	32	31	179
Other Noncurrent Operating Assets	26	42	44	48	52	52	53	61
Total Liabilities & Shareholders' Equity	485	482	473	482	398	404	422	837
Total Liabilities	157	154	150	161	75	77	84	503
Total Current Liabilities	40	42	42	49	37	41	48	63
Accounts Payable	3.21	3.16	1.05	5.69	6.53	5.79	5.59	5.18
Accrued Expenses	25	22	23	26	17	21	28	27
Current Deferred Revenue	9.42	9.85	8.81	9.31	12	13	13	29
Other Current Liabilities	-	3.12	3.17	1.49	1.24	1.28	1.31	1.56
Total Noncurrent Liabilities	117	112	109	111	38	36	36	440
Long-Term Debt	82	80	78	76	-	-	-	395
Capital Lease Obligations	-	16	-	18	18	-	17	17
Noncurrent Deferred Revenue	18	14	14	15	18	16	16	26
Noncurrent Deferred & Payable Income Tax Liabilities	0.34	1.79	1.83	1.86	1.74	1.76	1.77	2.35
Other Noncurrent Operating Liabilities	16	0.35	15	0.38	0.23	18	0.22	0.22
Total Equity & Noncontrolling Interests	328	328	323	322	323	327	339	334
Total Preferred & Common Equity	328	328	323	322	323	327	339	334
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	328	328	323	322	323	327	339	334
Common Stock	695	718	730	744	770	786	807	818
Retained Earnings	-368	-389	-407	-423	-447	-459	-469	-484

This table displays calculated financial ratios and metrics derived from Alkami Technology's official financial filings.

Metric	2019	2020	2021	2022	2023	2024
Period end date	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Growth Metrics	-	-	-	-	-	-
Revenue Growth	0.00%	52.49%	35.68%	34.25%	29.65%	26.06%
EBITDA Growth	0.00%	-20.95%	11.70%	-17.01%	-5.48%	35.29%
EBIT Growth	0.00%	-21.17%	9.76%	-25.98%	-9.12%	29.36%
NOPAT Growth	0.00%	17.47%	-22.26%	-34.42%	-10.43%	29.95%
Net Income Growth	0.00%	-22.66%	8.83%	-25.15%	-7.36%	35.09%
EPS Growth	0.00%	-18.87%	93.80%	12.33%	-4.69%	38.81%
Operating Cash Flow Growth	0.00%	2.41%	24.08%	-31.38%	54.00%	206.26%
Free Cash Flow Firm Growth	0.00%	0.00%	15.29%	-282.17%	72.70%	27.97%
Invested Capital Growth	0.00%	0.00%	60.32%	266.51%	4.75%	3.64%
Revenue Q/Q Growth	0.00%	0.00%	6.37%	6.85%	6.36%	5.80%
EBITDA Q/Q Growth	0.00%	0.00%	-1.31%	15.77%	-16.75%	11.13%
EBIT Q/Q Growth	0.00%	0.00%	-1.75%	11.86%	-13.99%	8.90%
NOPAT Q/Q Growth	0.00%	0.00%	-4.37%	11.56%	-13.58%	9.11%
Net Income Q/Q Growth	0.00%	0.00%	-1.88%	12.59%	-14.15%	11.04%
EPS Q/Q Growth	0.00%	0.00%	84.73%	-166.67%	-15.52%	14.58%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	9.01%	-4.59%	32.74%	158.98%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	-4.56%	31.00%	11.88%
Invested Capital Q/Q Growth	0.00%	0.00%	8.23%	9.19%	-4.67%	-5.34%
Profitability Metrics	-	-	-	-	-	-
Gross Margin	41.39%	52.75%	55.08%	53.03%	54.42%	58.90%
EBITDA Margin	-54.06%	-42.88%	-27.90%	-24.32%	-19.79%	-10.16%
Operating Margin	-57.84%	-31.30%	-28.20%	-28.24%	-24.06%	-13.37%
EBIT Margin	-57.15%	-45.41%	-30.20%	-28.34%	-23.85%	-13.37%
Profit (Net Income) Margin	-56.93%	-45.79%	-30.77%	-28.69%	-23.76%	-12.23%
Tax Burden Percent	100.00%	100.00%	100.37%	99.22%	100.07%	100.76%
Interest Burden Percent	99.63%	100.85%	101.52%	102.02%	99.52%	90.81%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	-129.91%	-61.01%	-28.55%	-19.60%	-13.18%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	-92.17%	-53.13%	-19.34%	-1.63%	-3.94%
Return on Net Nonoperating Assets (RNNOA)	0.00%	72.77%	43.15%	11.28%	0.50%	1.20%
Return on Equity (ROE)	0.00%	-57.14%	-17.86%	-17.27%	-19.09%	-11.98%
Cash Return on Invested Capital (CROIC)	0.00%	-329.91%	-107.35%	-142.80%	-24.23%	-16.75%
Operating Return on Assets (OROA)	0.00%	-20.44%	-13.40%	-12.51%	-14.22%	-10.66%
Return on Assets (ROA)	0.00%	-20.61%	-13.66%	-12.66%	-14.16%	-9.76%
Return on Common Equity (ROCE)	0.00%	83.78%	-2.76%	-17.27%	-19.09%	-11.98%
Return on Equity Simple (ROE_SIMPLE)	0.00%	19.49%	-13.59%	-17.54%	-19.36%	-11.44%
Net Operating Profit after Tax (NOPAT)	-30	-25	-30	-40	-45	-31
NOPAT Margin	-40.49%	-21.91%	-19.74%	-19.77%	-16.84%	-9.36%
Net Nonoperating Expense Percent (NNEP)	0.00%	-37.75%	-7.88%	-9.21%	-17.97%	-9.23%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-9.65%	-13.72%	-8.75%
Cost of Revenue to Revenue	58.61%	47.25%	44.92%	46.97%	45.58%	41.10%
SG&A Expenses to Revenue	33.89%	32.49%	33.12%	34.88%	27.53%	25.06%
R&D to Revenue	44.49%	35.86%	32.07%	33.94%	31.97%	28.82%
Operating Expenses to Revenue	99.22%	84.05%	83.28%	81.27%	78.47%	72.27%
Earnings before Interest and Taxes (EBIT)	-42	-51	-46	-58	-63	-45
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-40	-48	-42	-50	-52	-34
Valuation Ratios	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	5.13	4.00	7.12	10.32
Price to Tangible Book Value (P/TBV)	0.00	0.00	6.20	9.30	16.39	20.48
Price to Revenue (P/Rev)	2.45	1.61	11.62	6.53	8.73	11.04
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	12.72	24.47	5.50	9.54	14.80
Enterprise Value to Revenue (EV/Rev)	0.00	4.29	9.75	5.99	8.38	10.69
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	191.99
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-
Debt to Equity	0.00	0.14	0.07	0.25	0.00	0.00
Long-Term Debt to Equity	0.00	0.14	0.07	0.24	0.00	0.00
Financial Leverage	0.00	-0.79	-0.81	-0.58	-0.31	-0.30
Leverage Ratio	0.00	1.39	1.31	1.36	1.35	1.23
Compound Leverage Factor	0.00	1.40	1.33	1.39	1.34	1.11
Debt to Total Capital	0.00%	12.16%	6.67%	20.20%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.15%	0.42%	0.76%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	12.01%	6.24%	19.44%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	216.63%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	0.00%	-128.79%	93.33%	79.80%	100.00%	100.00%
Debt to EBITDA	0.00	-0.52	-0.58	-1.70	0.00	0.00
Net Debt to EBITDA	0.00	2.95	6.69	2.25	0.00	0.00
Long-Term Debt to EBITDA	0.00	-0.51	-0.54	-1.64	0.00	0.00
Debt to NOPAT	0.00	-1.01	-0.82	-2.09	0.00	0.00
Net Debt to NOPAT	0.00	5.78	9.45	2.77	0.00	0.00
Long-Term Debt to NOPAT	0.00	-1.00	-0.77	-2.02	0.00	0.00
Altman Z-Score	0.00	0.68	11.40	4.62	17.47	26.84
Noncontrolling Interest Sharing Ratio	0.00%	246.61%	84.54%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-
Current Ratio	0.00	9.43	10.40	5.82	3.77	3.98
Quick Ratio	0.00	8.83	9.92	5.35	3.24	3.39
Cash Flow Metrics	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-62	-53	-202	-55	-40
Operating Cash Flow to CapEx	-1,059.50%	-1,776.67%	-783.31%	-855.91%	-278.16%	236.75%
Free Cash Flow to Firm to Interest Expense	0.00	-127.61	-44.57	-52.23	-7.08	-86.15
Operating Cash Flow to Interest Expense	-355.32	-78.01	-24.42	-9.84	-2.25	40.34
Operating Cash Flow Less CapEx to Interest Expense	-388.85	-82.40	-27.53	-10.99	-3.05	23.30
Efficiency Ratios	-	-	-	-	-	-
Asset Turnover	0.00	0.45	0.44	0.44	0.60	0.80
Accounts Receivable Turnover	0.00	7.95	8.71	8.68	8.58	8.99
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	10.72	13.65	16.09	17.36	17.11
Accounts Payable Turnover	0.00	147.18	34.10	24.17	20.51	20.17
Days Sales Outstanding (DSO)	0.00	45.90	41.89	42.05	42.55	40.58
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	2.48	10.70	15.10	17.79	18.10
Cash Conversion Cycle (CCC)	0.00	43.42	31.18	26.95	24.76	22.49
Capital & Investment Metrics	-	-	-	-	-	-
Invested Capital	0.00	38	61	222	233	241
Invested Capital Turnover	0.00	5.93	3.09	1.44	1.16	1.41
Increase / (Decrease) in Invested Capital	0.00	38	23	162	11	8.48
Enterprise Value (EV)	0.00	481	1,484	1,223	2,220	3,570
Market Capitalization	180	180	1,768	1,335	2,313	3,686
Book Value per Share	$0.00	($54.79)	$3.91	$3.65	$3.41	$3.55
Tangible Book Value per Share	$0.00	($59.88)	$3.24	$1.57	$1.48	$1.79
Total Capital	0.00	205	369	419	325	357
Total Debt	0.00	25	25	85	0.00	0.00
Total Long-Term Debt	0.00	25	23	81	0.00	0.00
Net Debt	0.00	-142	-284	-112	-92	-116
Capital Expenditures (CapEx)	3.69	2.15	3.70	4.45	6.29	7.86
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	6.28	4.95	7.38	17	20
Debt-free Net Working Capital (DFNWC)	0.00	173	314	204	109	136
Net Working Capital (NWC)	0.00	173	312	201	109	136
Net Nonoperating Expense (NNE)	12	27	17	18	18	9.60
Net Nonoperating Obligations (NNO)	0.00	-142	-284	-112	-92	-116
Total Depreciation and Amortization (D&A)	2.27	2.84	3.49	8.21	11	11
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	5.60%	3.25%	3.61%	6.43%	6.01%
Debt-free Net Working Capital to Revenue	0.00%	154.33%	206.05%	99.74%	41.22%	40.68%
Net Working Capital to Revenue	0.00%	154.05%	205.02%	98.18%	41.22%	40.68%
Earnings Adjustments	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	($0.73)	($0.64)	($0.67)	($0.41)
Adjusted Weighted Average Basic Shares Outstanding	0.00	0.00	64.51M	90.96M	94.08M	98.89M
Adjusted Diluted Earnings per Share	$0.00	$0.00	($0.73)	($0.64)	($0.67)	($0.41)
Adjusted Weighted Average Diluted Shares Outstanding	0.00	0.00	64.51M	90.96M	94.08M	98.89M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	90.22M	92.30M	96.76M	102.23M
Normalized Net Operating Profit after Tax (NOPAT)	-30	-24	-28	-49	-44	-31
Normalized NOPAT Margin	-40.49%	-21.39%	-18.37%	-24.06%	-16.77%	-9.32%
Pre Tax Income Margin	-56.93%	-45.79%	-30.66%	-28.91%	-23.74%	-12.14%
Debt Service Ratios	-	-	-	-	-	-
EBIT to Interest Expense	-382.05	-104.13	-38.74	-14.97	-8.11	-96.80
NOPAT to Interest Expense	-270.68	-50.25	-25.33	-10.44	-5.72	-67.76
EBIT Less CapEx to Interest Expense	-415.59	-108.52	-41.86	-16.12	-8.91	-113.84
NOPAT Less CapEx to Interest Expense	-304.21	-54.64	-28.45	-11.59	-6.53	-84.80
Payout Ratios	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	-10.61%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	-30.55%	-27.73%	0.00%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Alkami Technology's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	34.33%	30.88%	33.95%	30.15%	26.76%	28.50%	26.89%	24.93%	26.89%	25.62%	28.52%
EBITDA Growth	-67.73%	77.84%	-16.46%	13.25%	25.75%	-283.84%	31.52%	30.10%	40.49%	41.75%	-21.90%
EBIT Growth	-78.41%	59.81%	-27.38%	9.04%	21.59%	-148.11%	26.79%	25.44%	33.09%	33.57%	-25.65%
NOPAT Growth	-77.88%	57.92%	-30.29%	7.80%	20.34%	-139.03%	27.03%	26.11%	33.95%	34.15%	-24.51%
Net Income Growth	-78.71%	63.20%	-26.53%	12.22%	22.81%	-158.82%	32.60%	30.65%	38.99%	39.88%	31.64%
EPS Growth	-69.23%	-103.23%	-20.00%	13.64%	27.27%	-180.00%	33.33%	31.58%	43.75%	50.00%	33.33%
Operating Cash Flow Growth	-5.14%	-13.72%	-15.22%	48.69%	165.91%	61.63%	109.89%	109.60%	251.25%	215.19%	-695.58%
Free Cash Flow Firm Growth	-152.85%	-418.16%	-328.24%	80.52%	67.97%	88.08%	89.69%	45.58%	65.19%	26.37%	-2,004.95%
Invested Capital Growth	263.28%	266.51%	261.83%	11.15%	19.97%	4.75%	4.41%	4.40%	4.38%	3.64%	156.39%
Revenue Q/Q Growth	5.70%	3.98%	8.03%	9.61%	2.95%	5.41%	6.67%	7.92%	4.56%	4.37%	9.12%
EBITDA Q/Q Growth	1.58%	84.71%	-432.47%	-8.25%	15.77%	20.94%	5.01%	-10.50%	28.30%	22.61%	-98.78%
EBIT Q/Q Growth	-1.22%	73.67%	-219.76%	-6.73%	12.75%	16.68%	5.64%	-8.70%	21.71%	17.28%	-78.48%
NOPAT Q/Q Growth	-2.24%	72.35%	-209.23%	-5.47%	11.67%	17.03%	5.60%	-6.81%	21.04%	17.28%	-78.48%
Net Income Q/Q Growth	0.91%	75.50%	-245.34%	-4.70%	12.87%	17.85%	10.07%	-7.73%	23.34%	19.05%	-2.26%
EPS Q/Q Growth	0.00%	77.27%	-260.00%	-5.56%	15.79%	12.50%	14.29%	-8.33%	30.77%	22.22%	-14.29%
Operating Cash Flow Q/Q Growth	57.35%	-191.30%	30.45%	40.61%	154.78%	-269.60%	117.93%	-42.38%	1,904.93%	-44.38%	-192.69%
Free Cash Flow Firm Q/Q Growth	11.57%	-2.51%	-13.43%	81.06%	-45.41%	61.86%	1.81%	0.06%	6.97%	19.35%	-2,707.11%
Invested Capital Q/Q Growth	-1.49%	9.19%	9.31%	-5.46%	6.32%	-4.67%	8.96%	-5.47%	6.31%	-5.34%	169.53%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	51.61%	51.63%	53.57%	53.94%	53.99%	55.98%	57.84%	59.36%	58.92%	59.35%	59.04%
EBITDA Margin	-32.43%	-4.77%	-23.51%	-23.22%	-19.00%	-14.25%	-12.69%	-12.99%	-8.91%	-6.61%	-12.03%
Operating Margin	-37.11%	-9.87%	-28.25%	-27.18%	-23.32%	-18.35%	-16.24%	-16.07%	-12.14%	-9.62%	-15.74%
EBIT Margin	-37.22%	-9.42%	-27.90%	-27.16%	-23.02%	-18.20%	-16.10%	-16.21%	-12.14%	-9.62%	-15.74%
Profit (Net Income) Margin	-37.54%	-8.84%	-28.27%	-27.01%	-22.86%	-17.81%	-15.02%	-14.99%	-10.99%	-8.52%	-7.99%
Tax Burden Percent	99.19%	90.08%	101.17%	100.50%	100.25%	97.85%	101.68%	101.52%	99.80%	99.39%	51.76%
Interest Burden Percent	101.68%	104.18%	100.19%	98.94%	99.04%	100.05%	91.77%	91.09%	90.73%	89.15%	98.08%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-38.25%	-9.97%	-27.99%	-20.47%	-18.15%	-14.95%	-12.86%	-14.25%	-10.74%	-9.48%	-8.66%
ROIC Less NNEP Spread (ROIC-NNEP)	-35.27%	-9.43%	-25.15%	-15.73%	-13.77%	-11.48%	-9.27%	-10.84%	-8.08%	-7.94%	-6.27%
Return on Net Nonoperating Assets (RNNOA)	21.67%	5.50%	13.52%	5.30%	4.28%	3.55%	2.20%	3.01%	1.97%	2.42%	-2.36%
Return on Equity (ROE)	-16.58%	-4.48%	-14.47%	-15.17%	-13.88%	-11.40%	-10.67%	-11.25%	-8.77%	-7.06%	-11.02%
Cash Return on Invested Capital (CROIC)	-148.84%	-142.80%	-141.21%	-29.85%	-35.69%	-24.23%	-20.98%	-20.54%	-18.06%	-16.75%	-95.14%
Operating Return on Assets (OROA)	-15.35%	-4.16%	-13.41%	-13.23%	-11.85%	-10.84%	-10.28%	-11.00%	-8.47%	-7.67%	-9.06%
Return on Assets (ROA)	-15.48%	-3.90%	-13.59%	-13.15%	-11.77%	-10.62%	-9.59%	-10.17%	-7.67%	-6.80%	-4.60%
Return on Common Equity (ROCE)	-16.58%	-4.48%	-14.47%	-15.17%	-13.88%	-11.40%	-10.67%	-11.25%	-8.77%	-7.06%	-11.02%
Return on Equity Simple (ROE_SIMPLE)	-20.45%	0.00%	-18.94%	-18.51%	-17.13%	0.00%	-17.77%	-15.87%	-13.56%	0.00%	-11.14%
Net Operating Profit after Tax (NOPAT)	-14	-3.84	-12	-13	-11	-9.17	-8.66	-9.24	-7.30	-6.04	-11
NOPAT Margin	-25.97%	-6.91%	-19.77%	-19.02%	-16.32%	-12.85%	-11.37%	-11.25%	-8.50%	-6.73%	-11.02%
Net Nonoperating Expense Percent (NNEP)	-2.98%	-0.54%	-2.83%	-4.74%	-4.39%	-3.48%	-3.60%	-3.41%	-2.66%	-1.54%	-2.40%
Return On Investment Capital (ROIC_SIMPLE)	-	-0.92%	-	-	-	-2.82%	-	-	-	-1.69%	-1.45%
Cost of Revenue to Revenue	48.39%	48.37%	46.43%	46.06%	46.01%	44.02%	42.16%	40.64%	41.08%	40.65%	40.96%
SG&A Expenses to Revenue	34.33%	30.85%	28.52%	27.69%	27.02%	27.03%	25.37%	25.09%	25.78%	24.07%	24.30%
R&D to Revenue	34.12%	36.65%	34.25%	31.73%	32.13%	30.11%	29.98%	29.10%	28.09%	28.27%	27.48%
Operating Expenses to Revenue	88.72%	61.49%	81.81%	81.12%	77.30%	74.33%	74.08%	75.44%	71.06%	68.97%	74.77%
Earnings before Interest and Taxes (EBIT)	-20	-5.23	-17	-18	-16	-13	-12	-13	-10	-8.63	-15
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-17	-2.65	-14	-15	-13	-10	-9.66	-11	-7.65	-5.92	-12
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	4.18	4.00	3.56	4.72	5.34	7.12	7.36	8.49	9.22	10.32	8.03
Price to Tangible Book Value (P/TBV)	9.96	9.30	8.40	11.25	12.61	16.39	16.89	18.93	19.54	20.48	0.00
Price to Revenue (P/Rev)	7.17	6.53	5.32	6.48	6.90	8.73	8.46	9.34	9.89	11.04	7.55
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	6.12	5.50	4.46	6.22	6.71	9.54	9.10	11.22	11.92	14.80	4.61
Enterprise Value to Revenue (EV/Rev)	6.52	5.99	4.94	6.09	6.58	8.38	8.22	9.05	9.63	10.69	8.44
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	423.12	191.99	250.37
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.26	0.25	0.31	0.26	0.31	0.00	0.06	0.00	0.05	0.00	1.23
Long-Term Debt to Equity	0.25	0.24	0.29	0.24	0.29	0.00	0.06	0.00	0.05	0.00	1.23
Financial Leverage	-0.61	-0.58	-0.54	-0.34	-0.31	-0.31	-0.24	-0.28	-0.24	-0.30	0.38
Leverage Ratio	1.38	1.36	1.36	1.46	1.49	1.35	1.35	1.35	1.37	1.23	1.88
Compound Leverage Factor	1.40	1.42	1.36	1.45	1.48	1.35	1.24	1.23	1.24	1.09	1.84
Debt to Total Capital	20.50%	20.20%	23.40%	20.56%	23.86%	0.00%	5.30%	0.00%	4.89%	0.00%	55.20%
Short-Term Debt to Total Capital	0.52%	0.76%	0.99%	1.31%	1.51%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	19.98%	19.44%	22.41%	19.25%	22.35%	0.00%	5.30%	0.00%	4.89%	0.00%	55.20%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	79.50%	79.80%	76.60%	79.44%	76.14%	100.00%	94.70%	100.00%	95.11%	100.00%	44.80%
Debt to EBITDA	-1.43	-1.70	-1.94	-1.69	-2.25	0.00	-0.38	0.00	-0.46	0.00	-11.43
Net Debt to EBITDA	2.11	2.25	1.65	1.88	1.73	0.00	1.44	0.00	2.19	0.00	-8.78
Long-Term Debt to EBITDA	-1.40	-1.64	-1.86	-1.58	-2.10	0.00	-0.38	0.00	-0.46	0.00	-11.43
Debt to NOPAT	-1.85	-2.09	-2.32	-1.98	-2.57	0.00	-0.44	0.00	-0.51	0.00	-12.34
Net Debt to NOPAT	2.72	2.77	1.97	2.21	1.97	0.00	1.67	0.00	2.43	0.00	-9.48
Long-Term Debt to NOPAT	-1.80	-2.02	-2.22	-1.86	-2.41	0.00	-0.44	0.00	-0.51	0.00	-12.34
Altman Z-Score	4.95	4.98	4.25	5.71	6.06	17.89	18.45	21.10	21.84	27.11	2.91
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	6.38	5.82	5.62	5.44	4.73	3.77	3.92	3.75	3.52	3.98	2.75
Quick Ratio	5.87	5.35	5.08	4.91	4.26	3.24	3.31	3.12	2.99	3.39	2.25
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-161	-165	-188	-36	-52	-20	-19	-19	-18	-15	-407
Operating Cash Flow to CapEx	-662.85%	-1,574.60%	-701.82%	-334.31%	203.25%	-316.72%	56.98%	26.38%	477.90%	337.62%	-293.32%
Free Cash Flow to Firm to Interest Expense	-136.20	-108.00	-106.82	-19.47	-26.77	-8.65	-265.18	-261.44	-99.99	-108.33	-508.72
Operating Cash Flow to Interest Expense	-4.01	-9.02	-5.47	-3.13	1.62	-2.33	13.03	7.41	61.04	45.60	-7.07
Operating Cash Flow Less CapEx to Interest Expense	-4.61	-9.60	-6.25	-4.06	0.82	-3.06	-9.84	-20.66	48.27	32.10	-9.48
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.41	0.44	0.48	0.49	0.51	0.60	0.64	0.68	0.70	0.80	0.58
Accounts Receivable Turnover	8.21	8.68	8.48	8.46	8.65	8.58	8.76	8.86	8.57	8.99	8.62
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	15.70	16.09	16.28	16.29	16.76	17.36	17.33	17.07	16.93	17.11	17.26
Accounts Payable Turnover	30.73	24.17	33.90	45.87	26.08	20.51	25.78	37.44	23.43	20.17	24.79
Days Sales Outstanding (DSO)	44.47	42.05	43.06	43.17	42.19	42.55	41.67	41.18	42.61	40.58	42.35
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	11.88	15.10	10.77	7.96	13.99	17.79	14.16	9.75	15.58	18.10	14.72
Cash Conversion Cycle (CCC)	32.59	26.95	32.29	35.21	28.20	24.76	27.51	31.44	27.03	22.49	27.63
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	204	222	243	230	244	233	254	240	255	241	650
Invested Capital Turnover	1.47	1.44	1.42	1.08	1.11	1.16	1.13	1.27	1.26	1.41	0.79
Increase / (Decrease) in Invested Capital	148	162	176	23	41	11	11	10	11	8.48	397
Enterprise Value (EV)	1,246	1,223	1,083	1,429	1,639	2,220	2,308	2,690	3,038	3,570	3,000
Market Capitalization	1,370	1,335	1,169	1,522	1,717	2,313	2,377	2,777	3,122	3,686	2,684
Book Value per Share	$3.60	$3.65	$3.55	$3.47	$3.41	$3.41	$3.34	$3.36	$3.42	$3.55	$3.27
Tangible Book Value per Share	$1.51	$1.57	$1.51	$1.46	$1.44	$1.48	$1.45	$1.50	$1.61	$1.79	($2.40)
Total Capital	412	419	428	406	422	325	341	327	356	357	746
Total Debt	85	85	100	83	101	0.00	18	0.00	17	0.00	412
Total Long-Term Debt	82	81	96	78	94	0.00	18	0.00	17	0.00	412
Net Debt	-124	-112	-85	-93	-77	-92	-69	-87	-84	-116	316
Capital Expenditures (CapEx)	0.72	0.88	1.37	1.71	1.54	1.68	1.67	2.08	2.30	1.81	1.93
Debt-free, Cash-free Net Working Capital (DFCFNWC)	8.55	7.38	13	14	12	17	21	24	20	20	16
Debt-free Net Working Capital (DFNWC)	217	204	199	190	190	109	108	111	121	136	111
Net Working Capital (NWC)	215	201	194	185	183	109	108	111	121	136	111
Net Nonoperating Expense (NNE)	6.18	1.08	5.10	5.25	4.43	3.54	2.78	3.07	2.14	1.60	-2.96
Net Nonoperating Obligations (NNO)	-124	-112	-85	-93	-77	-92	-69	-87	-84	-116	316
Total Depreciation and Amortization (D&A)	2.56	2.59	2.63	2.60	2.73	2.82	2.59	2.65	2.78	2.70	3.62
Debt-free, Cash-free Net Working Capital to Revenue	4.47%	3.61%	6.04%	5.84%	4.66%	6.43%	7.53%	8.09%	6.33%	6.01%	4.40%
Debt-free Net Working Capital to Revenue	113.72%	99.74%	90.51%	80.96%	76.25%	41.22%	38.60%	37.48%	38.33%	40.68%	31.21%
Net Working Capital to Revenue	112.61%	98.18%	88.57%	78.69%	73.69%	41.22%	38.60%	37.48%	38.33%	40.68%	31.21%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.22)	($0.05)	($0.18)	($0.19)	($0.16)	($0.14)	($0.12)	($0.13)	($0.09)	($0.07)	($0.08)
Adjusted Weighted Average Basic Shares Outstanding	91.18M	90.96M	92.40M	93.33M	94.68M	94.08M	96.95M	98.10M	99.44M	98.89M	102.43M
Adjusted Diluted Earnings per Share	($0.22)	($0.05)	($0.18)	($0.19)	($0.16)	($0.14)	($0.12)	($0.13)	($0.09)	($0.07)	($0.08)
Adjusted Weighted Average Diluted Shares Outstanding	91.18M	90.96M	92.40M	93.33M	94.68M	94.08M	96.95M	98.10M	99.44M	98.89M	102.43M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	91.48M	92.30M	92.86M	94.23M	95.36M	96.76M	97.52M	98.99M	100.50M	102.23M	103.02M
Normalized Net Operating Profit after Tax (NOPAT)	-13	-13	-12	-12	-11	-9.14	-8.61	-9.15	-7.30	-6.04	-7.95
Normalized NOPAT Margin	-25.01%	-22.89%	-19.55%	-18.99%	-16.32%	-12.81%	-11.31%	-11.14%	-8.50%	-6.73%	-8.13%
Pre Tax Income Margin	-37.84%	-9.82%	-27.95%	-26.87%	-22.80%	-18.20%	-14.77%	-14.77%	-11.01%	-8.58%	-15.44%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-16.77	-3.42	-9.53	-9.78	-8.07	-5.70	-167.85	-179.99	-57.93	-64.37	-19.22
NOPAT to Interest Expense	-11.71	-2.50	-6.75	-6.85	-5.72	-4.02	-118.57	-124.93	-40.55	-45.06	-13.45
EBIT Less CapEx to Interest Expense	-17.38	-3.99	-10.31	-10.72	-8.87	-6.43	-190.71	-208.05	-70.71	-77.88	-21.63
NOPAT Less CapEx to Interest Expense	-12.31	-3.08	-7.53	-7.79	-6.52	-4.76	-141.43	-153.00	-53.33	-58.57	-15.87
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Key Financial Trends

Alkami Technology (NASDAQ: ALKT) has demonstrated steady revenue growth over the past several years, with operating revenue rising from approximately $55.5 million in Q4 2022 to $97.8 million in Q1 2025. This represents a strong upward trend in top-line performance, reflecting ongoing business expansion.

Despite increasing revenue, the company has consistently operated at a loss, with net losses persisting throughout all quarters analyzed. For instance, net losses were around $4.9 million in Q4 2022 and expanded to roughly $7.8 million in Q1 2025. This continuation of net losses suggests Alkami is still in an investment phase or facing margin pressures.

Gross profit has grown from $28.7 million in Q4 2022 to about $57.8 million in Q1 2025, indicating improved efficiency or better pricing relative to cost of revenue, which is a positive sign. However, rising operating expenses, including selling, general & administrative (SG&A), marketing, and research & development (R&D) costs, have also increased substantially and are weighing on profitability.

The company's operating expenses increased from roughly $34.2 million in Q4 2022 to $73.2 million in Q1 2025, including charges such as impairment and restructuring expenses emerging more recently. These elevated costs have contributed to significant operating losses, indicating substantial investments in growth or restructuring efforts.

From a cash flow perspective, Alkami has often experienced negative net cash from operating activities in recent quarters, including a negative $5.7 million in Q1 2025, which is a cautionary indicator about cash burn. Investing activities have also seen large cash outflows, particularly Q1 2025 where net cash used in investing activities was $389.4 million mainly due to acquisitions and investments.

On the financing front, the company has generated substantial net cash inflows, including $362.4 million in Q1 2025, driven by issuance of debt, which appears to be funding its investment and operational cash needs. Alkami's balance sheet shows a sizeable increase in long-term debt, rising from approximately $15.7 million in Q2 2023 to nearly $395 million in Q1 2025, reflecting increased leverage.

Key considerations for investors include:

Consistent revenue growth from $55.5 million in Q4 2022 to $97.8 million in Q1 2025 shows strong top-line momentum.
Gross profit has more than doubled over the same period, suggesting improving business economics.
The company's substantial cash reserves and access to debt financing ($395 million in long-term debt as of Q1 2025) provide liquidity for growth initiatives.
Increased investment in R&D (up from $20.4 million in Q4 2022 to $26.9 million in Q1 2025) may drive future product innovation and competitive advantage.
Operating losses persist, but may be justified by growth investments at this stage of the company’s development.
Management is actively engaged in restructuring and incurring impairment charges, indicating strategic realignment.
The dilution effect is present with shares outstanding increasing slightly over time, but remains moderate.
Consistent net losses, with a negative trend in profitability and EPS declining to -$0.08 in Q1 2025 from -$0.05 in Q4 2022.
Negative operating cash flow in recent quarters (e.g., -$5.7 million in Q1 2025) and significant cash used in investing activities highlight high cash burn.
Rapidly increasing long-term debt raises concerns about financial leverage and future interest obligations.

In summary, Alkami is experiencing strong revenue growth and expanding gross profits but continues to face losses and cash flow challenges due to elevated operating expenses and investing activities. The company’s high leverage and cash burn pose risks, but its financial flexibility and focus on R&D investment may foster longer-term growth potential. Investors should weigh these growth dynamics against the ongoing profitability pressures and increased debt load.

08/28/25 10:49 PM ETAI Generated. May Contain Errors.

Financials Breakdown Chart

Frequently Asked Questions About Alkami Technology's Financials

When does Alkami Technology's financial year end?

According to the most recent income statement we have on file, Alkami Technology's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Alkami Technology's net income changed over the last 5 years?

Alkami Technology's net income appears to be on an upward trend, with a most recent value of -$40.84 million in 2024, falling from -$41.87 million in 2019. The previous period was -$62.91 million in 2023. View Alkami Technology's forecast to see where analysts expect Alkami Technology to go next.

What is Alkami Technology's operating income?

Alkami Technology's total operating income in 2024 was -$44.63 million, based on the following breakdown:

Total Gross Profit: $196.63 million
Total Operating Expenses: $241.26 million

How has Alkami Technology's revenue changed over the last 5 years?

Over the last 5 years, Alkami Technology's total revenue changed from $73.54 million in 2019 to $333.85 million in 2024, a change of 354.0%.

How much debt does Alkami Technology have?

Alkami Technology's total liabilities were at $80.25 million at the end of 2024, a 7.2% increase from 2023, and a 15.6% increase since 2020.

How much cash does Alkami Technology have?

In the past 4 years, Alkami Technology's cash and equivalents has ranged from $40.93 million in 2023 to $308.58 million in 2021, and is currently $94.36 million as of their latest financial filing in 2024.

How has Alkami Technology's book value per share changed over the last 5 years?

Over the last 5 years, Alkami Technology's book value per share changed from 0.00 in 2019 to 3.55 in 2024, a change of 355.3%.

Related Companies

This page (NASDAQ:ALKT) was last updated on 8/28/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Alkami Technology (ALKT) Financials

Key Financial Trends

Financials Breakdown Chart

Frequently Asked Questions About Alkami Technology's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Alkami Technology (ALKT) Financials

Annual Income Statements for Alkami Technology

Quarterly Income Statements for Alkami Technology

Annual Cash Flow Statements for Alkami Technology

Quarterly Cash Flow Statements for Alkami Technology

Annual Balance Sheets for Alkami Technology

Quarterly Balance Sheets for Alkami Technology

Annual Metrics And Ratios for Alkami Technology

Quarterly Metrics And Ratios for Alkami Technology

Key Financial Trends

Financials Breakdown Chart

Frequently Asked Questions About Alkami Technology's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools